药物对比
Fremanezumab vs Zolmitriptan
Fremanezumab (Ajovy) is a CGRP monoclonal antibody for migraine prevention, while Zolmitriptan (Zomig) is a triptan for acute migraine treatment. Compare their mechanisms, side effects, and usage.
此页面暂无可用的对比维度。
临床背景
Patients with frequent migraines often compare preventive options like Fremanezumab to acute treatments like Zolmitriptan to manage their condition effectively.
结论
Both drugs are effective for migraine but target different aspects—Fremanezumab prevents attacks while Zolmitriptan treats them, making selection based on your specific migraine pattern.
全部药物对比